menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Overview of the Glycemic Control Algorithm from the 2020 AACE/ACE Consensus Statement

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

Here’s a breakdown of the glycemic control algorithm that’s part of the American College of Endocrinology Consensus Statement for 2020.

  • Sponsored by

  • Overview

    The glycemic control algorithm that’s part of the American College of Endocrinology Consensus Statement for 2020 is separated into several parts, and here to break them down for us is Dr. Pablo Mora, Clinical Professor with the Division of Endocrinology at the University of Texas Western Medical Center of Dallas.

    Novo Nordisk is a registered trademark of Novo Nordisk A/S.
    © 2020 Novo Nordisk All rights reserved. US20DI00336 October 2020
Programs 9/23/21